The Latest Cardiac and Vascular News
Dr. Siddiqui is recognized for his extensive experience in Microsurgical, Radiosurgical and Endovascular Techniques for the Comprehensive Management of Vascular Disease TEL AVIV, Israel, Feb. 15, 2022 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of […]
RALEIGH, N.C., Feb. 10, 2022 /PRNewswire/ — Contego Medical has announced that Steve MacKinnon has joined the organization as their Chief Commercialization Officer. Mr. MacKinnon is an accomplished senior medical device executive with significant commercialization experience, a track record of success, and a history of driving growth by building and managing highly motivated sales teams. […]
Oversubscribed Round Includes Strategic, Institutional, Venture, and Individual Investors. BURLINGTON, Vt.–(BUSINESS WIRE)–CoreMap announced today it has closed a $3 million Series A Milestone financing concurrently with a $20 million Series B financing. The financing includes a diverse group of strategic, institutional, venture and individual partners. Founded in 2016, CoreMap’s mission […]
MOUNTAIN VIEW, Calif., Feb. 10, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the appointment of Patricia Baran as Senior Vice President, Healthcare Americas. In this role, Baran will report to Vincent Balsamo, Executive Vice President of Worldwide Sales. Baran will lead the Employer, Payor, and Health System business segments […]
New look and logo to position Radcliffe as a multimedia knowledge network and global market leader for the cardiovascular community. LONDON, England, Feb. 10, 2022 (GLOBE NEWSWIRE) — Radcliffe Group has unveiled a new brand identity across its core business, including its three specialist channels: Radcliffe Cardiology, Radcliffe Vascular, and Radcliffe Medical Education. The […]
Financial Results and Highlights Recent Period Activity − Achieved Fourth Quarter and Full Year 2021 Global Net Product Revenues of $199 Million and $662 Million, Respectively, Representing 83% Annual Growth Compared to 2020 – − Reported Positive 18-Month Results from HELIOS-A Phase 3 Study of Vutrisiran in hATTR Amyloidosis Patients with […]
On behalf of Johnson & Johnson, we have exciting organizational news to share, which will continue to help advance our mission to enable a healthier future for patients. Celine Martin has recently been appointed to the new role of Company Group Chairman, Cardiovascular & Specialty Solutions (CSS) Group. In this […]
Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health Investors and existing investors GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic […]
THOUSAND OAKS, Calif., Feb. 7, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year 2021 versus comparable periods in 2020. Key results include: For the fourth quarter, total revenues increased 3% to $6.8 billion in comparison to the fourth quarter of 2020, driven by increased Other Revenue […]
Full-Year 2021 Revenues of $81.3 Billion, Reflecting 92% Operational Growth; Excluding Contributions from Comirnaty(1) and Paxlovid, Revenues Grew 6% Operationally to $44.4 Billion Fourth-Quarter 2021 Revenues of $23.8 Billion, Reflecting 106% Operational Growth; Excluding Contributions from Comirnaty(1) and Paxlovid, Revenues Declined 2% Operationally Driven Primarily by the Impact of Fewer Selling Days […]
